Skip Navigation

The key to achieving this mission lies in understanding the inner workings of the immune synapse – the interface between a T cell and a cell that presents an intracellular antigen – based on the application of our proprietary DECODETM platform. We are using DECODE to generate insights into key factors that govern immune function in different diseases – an approach that we believe will enable us to identify the specific immune-based drivers at the origins of disease onset and progression – allowing for the development of more precise medicines.



“Through our broad and deep knowledge of the T cell repertoire, we are harnessing this elegant creation of biology to develop an entirely new class of powerful immune medicines."

– John Cox, CEO